Soluble Fas (CD95) Is a Prognostic Factor in Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation-Reference-Cited by-同舟云学术

Soluble Fas (CD95) Is a Prognostic Factor in Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation

Published:2001-12 Issue:6 Volume:10 Page:759-768
ISSN:1525-8165
Container-title:Journal of Hematotherapy & Stem Cell Research
language:en
Short-container-title:Journal of Hematotherapy & Stem Cell Research

Author:

Bewick M.¹,Conlon M.¹,Parissenti A.M.¹,Lee H.¹,Zhang L.¹,Glück S.²,Lafrenie R.M.¹

Affiliation:

1. Northeastern Ontario Regional Cancer Center, Sudbury, Ontario, P3E 5J1 Canada

2. Tom Baker Cancer Center, University of Calgary, Calgary, Alberta, Canada

Publisher

Mary Ann Liebert Inc

Subject

Hematology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/152581601317210854

Reference50 articles.

1. Apoptosis by Death Factor

2. Deficient activation of CD95 (APO-1/ Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma

3. True

4. Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study;Breast Cancer Research;2023-03-21

2. Plasma Cytokine Levels and Cytokine Genetic Polymorphisms in Patients with Metastatic Breast Cancer Receiving High-Dose Chemotherapy;Immuno;2023-01-14

3. The role of CD95 and CD95 ligand in cancer;Cell Death & Differentiation;2015-02-06

4. A computational model to predict bone metastasis in breast cancer by integrating the dysregulated pathways;BMC Cancer;2014-08-27

5. High-Dose Chemotherapy with Autologous Stem Cell Transplant for Breast Cancer: What Have We Learned 25 Years Later?;Biology of Blood and Marrow Transplantation;2012-01